Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
NCT ID NCT04734704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether the community of bacteria living on the skin (the skin microbiome) plays a role in vitiligo—a condition that causes white patches—and in side effects from anti-PD-1 immunotherapy for advanced melanoma. Researchers will collect skin swabs from people with vitiligo, melanoma patients who developed vitiligo during treatment, and those who did not. By analyzing the genetic material of skin microbes, they hope to uncover connections that could lead to better understanding of these conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could reveal how skin microbes influence autoimmune conditions and treatment side effects, potentially guiding future therapies.
What could go wrong
This is an observational study with a small sample size (57 people). It aims to understand, not treat, so direct patient benefits are not guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Dermatologie - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France